On the Science of SARS

REUTERS/Simon Kwong  The Taiwan Post Office released a series of anti-SARS stamps. Funds collected were designated to fight the disease, which was declared under control in Taiwan on July 5. November 2002: Initial cases of a severe, new pneumonia appear in Guangdong Province, South China. The World Health Organization (WHO) is not warned. Feb. 28, 2003: Hanoi, Vietnam, asks WHO representative Carlo Urbani for assistance with a similar disease. Urbani warns WHO of probable existence of

Written byRobert Walgate
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

November 2002: Initial cases of a severe, new pneumonia appear in Guangdong Province, South China. The World Health Organization (WHO) is not warned.

Feb. 28, 2003: Hanoi, Vietnam, asks WHO representative Carlo Urbani for assistance with a similar disease. Urbani warns WHO of probable existence of new infection.

March 15: WHO issues emergency travel advisory, and creates network of 11 labs [including Hong Kong but not mainland China] to identify cause.

March 17: Human metapneumovirus isolated.

March 18: Hunt for SARS agent intensifies; 250 causes ruled out (www.the-scientist.com/news/20030318/05).

March 20: Guangdong doctor linked to SARS outbreak in Hong Kong (www.the-scientist.com/news/20030320/09).

March 21: Hong Kong and Germany isolate new agent. The Netherlands finds all German cases negative for human metapneumovirus.

March 22: Hong Kong scientists see coronavirus-like particles; US scientists confirm. US, Canada, France, and Hong Kong continue to find human metapneumovirus.

March 23: France and Canada find coronavirus. Germany, Japan, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies